Mikkel Østergaard
Impact in
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Musculoskeletal synovial abnormalities and treatments
- Orthopedics and Sports Medicine top 0.2%
- Bone and Joint Diseases
Papers in
- Rheumatology 414
- Rheumatoid Arthritis Research and Therapies 290
- Spondyloarthritis Studies and Treatments 180
- Musculoskeletal synovial abnormalities and treatments 36
- Systemic Lupus Erythematosus Research 36
-
- Bone and Joint Diseases 60
- Co-authors
- Susanne Juhl Pedersen (88 shared papers)Merete Lund Hetland (130 shared papers)Marcin Szkudlarek (19 shared papers)P. G. Conaghan (87 shared papers)Robert G. Lambert (47 shared papers)Bo Ejbjerg (39 shared papers)Mette Klarlund (20 shared papers)Walter P. Maksymowych (61 shared papers)
- Journals
- Annals of the Rheumatic Diseases (91 papers)The Journal of Rheumatology (65 papers)Lara D. Veeken (41 papers)Arthritis Research & Therapy (33 papers)Scandinavian Journal of Rheumatology (25 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Mikkel Østergaard
504 papers receiving 18.7k citations
Mikkel Østergaard's Hit Papers
Peers
Comparison fields: 5 of 147
- Rheumatology 14.7k
- Orthopedics and Sports Medicine 2.0k
- Hematology 2.5k
- Immunology 2.3k
- Rehabilitation 294
Countries citing papers authored by Mikkel Østergaard
This map shows the geographic impact of Mikkel Østergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikkel Østergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikkel Østergaard more than expected).
Fields of papers citing papers by Mikkel Østergaard
This network shows the impact of papers produced by Mikkel Østergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikkel Østergaard. The network helps show where Mikkel Østergaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Mikkel Østergaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 522 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group Hit paper breakdown → | 2009 | 699 |
| 2 | OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. Hit paper breakdown → | 2003 | 633 |
| 3 | Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis Hit paper breakdown → | 2003 | 595 |
| 4 | EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis Hit paper breakdown → | 2013 | 496 |
| 5 | Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry Hit paper breakdown → | 2009 | 436 |
| 6 | 2004 | 328 | |
| 7 | Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study Hit paper breakdown → | 2018 | 309 |
| 8 | 2008 | 285 | |
| 9 | 2010 | 263 | |
| 10 | 2005 | 239 | |
| 11 | 1997 | 218 | |
| 12 | 2006 | 217 | |
| 13 | 2012 | 204 | |
| 14 | 1998 | 204 | |
| 15 | 2006 | 204 | |
| 16 | 2010 | 193 | |
| 17 | Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. | 2008 | 187 |
| 18 | 2010 | 186 | |
| 19 | 2007 | 171 | |
| 20 | 2010 | 170 |
About Mikkel Østergaard
Mikkel Østergaard is a scholar working on Rheumatology, Orthopedics and Sports Medicine, Hematology, Immunology and Pathology and Forensic Medicine, having authored 522 papers that have together received 19.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (290 papers), Spondyloarthritis Studies and Treatments (180 papers), Bone and Joint Diseases (60 papers), Musculoskeletal synovial abnormalities and treatments (36 papers), Systemic Lupus Erythematosus Research (36 papers), Autoimmune and Inflammatory Disorders Research (33 papers), Psoriasis: Treatment and Pathogenesis (27 papers) and Orthopedic Surgery and Rehabilitation (11 papers). The work is most often cited by research in Rheumatology (14.7k citations), Orthopedics and Sports Medicine (2.0k citations), Hematology (2.5k citations), Immunology (2.3k citations) and Rehabilitation (294 citations). Mikkel Østergaard has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Susanne Juhl Pedersen, Merete Lund Hetland, Marcin Szkudlarek, P. G. Conaghan, Robert G. Lambert, Bo Ejbjerg, Mette Klarlund, Walter P. Maksymowych, Henrik S. Thomsen and Michel Court‐Payen. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Lara D. Veeken, Arthritis Research & Therapy and Scandinavian Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.